CausalSentinel

Protein Dossier — CTSA (Lysosomal protective protein)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Mean platelet volume -0.0762 0.00644 3.14e-32 Wald ratio 1 trans NA
Triglycerides -0.161 0.0193 1.01e-16 Wald ratio 1 trans 0.989
Platelet count 19.3 2.43 1.79e-15 Wald ratio 1 trans 0.65
Diastolic blood pressure automated reading -0.0939 0.0144 7.83e-11 Wald ratio 1 trans 0.157
HDL cholesterol 0.114 0.0199 1.16e-08 Wald ratio 1 trans 0.967
Sodium in urine -0.0748 0.0139 7.01e-08 Wald ratio 1 trans 0.899
Body mass index (BMI) -0.0747 0.0141 1.18e-07 Wald ratio 1 trans 0.111
Non-cancer illness code self-reported: hypertension -0.124 0.0273 5.28e-06 Wald ratio 1 trans NA
Non-cancer illness code self-reported: deep venous thrombosis (dvt) 0.33 0.0724 5.28e-06 Wald ratio 1 trans NA
Diagnoses - main ICD10: K80 Cholelithiasis 0.32 0.0718 8.32e-06 Wald ratio 1 trans NA
Height 0.0703 0.0176 6.33e-05 Wald ratio 1 trans NA
Creatinine (enzymatic) in urine -0.0524 0.0135 1.03e-04 Wald ratio 1 trans NA
…and 118 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3179_51_2 Cathepsin A Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

2 association rows across 2 traits (2 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Lysosomal protective protein levels 1e-8 rs2075962 1 GCST90425637 no MR -> candidate analysis
Body shape phenotype PC2 3e-8 rs6104390 1 GCST90832990 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1827 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
galactosialidosis 0.922 established (curated) no MR -> candidate analysis
cathepsin a-related arteriopathy-strokes-leukoencephalopathy 0.486 established (curated) no MR -> candidate analysis
hereditary disease 0.742 established (curated) no MR -> candidate analysis
Lynch syndrome 0.559 established (curated) no MR -> candidate analysis
Non-immune hydrops fetalis 0.438 established (curated) no MR -> candidate analysis
Abnormality of prenatal development or birth 0.438 established (curated) no MR -> candidate analysis
coronary artery disorder 0.276 common-variant locus no MR -> candidate analysis
prostate carcinoma 0.201 common-variant locus no MR -> candidate analysis
breast carcinoma 0.201 common-variant locus no MR -> candidate analysis
ovarian dysfunction 0.18 common-variant locus no MR -> candidate analysis
macular degeneration 0.148 common-variant locus no MR -> candidate analysis
abdominal aortic aneurysm 0.102 common-variant locus no MR -> candidate analysis
familial hyperlipidemia 0.103 common-variant locus no MR -> candidate analysis

Of the 13 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Lysosomal protective protein)
gnomAD constraint pLI=6.1e-09, LOEUF=0.815 — LoF-tolerant
GWAS Catalog 122 unique SNPs / 294 rows
ClinVar 635 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance